BronchiectasisEQOPEPNCT06820983
Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP
A study testing adult questionnary for parents of children aged 8 to 13, Quality of life questionnaire for children aged 8 to 13 and Quality of life questionnaire for adolescents aged 14 to 17 in people with Bronchiectasis and Quality of Life, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.
Trial summary
To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular. Read more about this study
- Who is it for?
- Ages 8 years and older
- Conditions the study is for
- Bronchiectasis, Quality of Life, Physiotherapy
- What is being tested?
- adult questionnary for parents of children aged 8 to 13, Quality of life questionnaire for children aged 8 to 13 and Quality of life questionnaire for adolescents aged 14 to 17
- How many people
- 60 participants
- Where
- 1 siteFrance
- Study dates
- 17 Oct 2024to Apr 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP.
- The study population will be clinically stable and will be seen in follow-up consultations.
Who cannot join
- Children under 8 years of age.
- Patients who use an OPEP
- Patients in the acute exacerbation phase of their DDB
- Patients who are not under regular consultation
- Patients with severe, uncontrolled co-morbidities
- Patients with cognitive or psychiatric disorders preventing proper adherence to the study protocol
- Patients taking part simultaneously in another clinical study that could interfere with the results of the OPEP study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
CHU Amiens-Picardie
Amiens, 80054
Thomas Pinto, MD, 33+22088000, pinto.thomas@chu-amiens.fr
About this study
To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.
- Conditions
- Bronchiectasis, Quality of Life, Physiotherapy
- Being tested
- adult questionnary for parents of children aged 8 to 13, Quality of life questionnaire for children aged 8 to 13, Quality of life questionnaire for adolescents aged 14 to 17, Quality of life questionnaire for adults, A satisfaction adherence questionnaire
- Keywords
- quality of life, Bronchiectasis, oscillating PEP devices, physiotherapy
- Medical subject headings
- Bronchiectasis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
adult questionnary for parents of children aged 8 to 13Other
Quality of life questionnaire for parents of children aged 8 to 13
Quality of life questionnaire for children aged 8 to 13Other
Quality of life questionnaire for children aged 8 to 13
Quality of life questionnaire for adolescents aged 14 to 17Other
Quality of life questionnaire for adolescents aged 14 to 17
Quality of life questionnaire for adultsOther
Quality of life questionnaire for adults
A satisfaction adherence questionnaireOther
A satisfaction adherence questionnaire will also be distributed to patients after several months' use of oscillating PEP
What is being measured
The primary outcome is the main question the study is designed to answer.
Variation of patient quality of life before and after OPEP installation
quality of life is determined by qustionnaire
Measured: 18 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Feb 2025
- Study start17 Oct 2024
- Primary completionApr 2026 (estimated)
- Study completionApr 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BronchiectasisStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire, AmiensThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Sponsor type
- University, hospital or other
- Collaborators
- Hôpital Armand Trousseau
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06820983
- Sponsor's protocol ID
- PI2024_843_0118
- Acronym
- EQOPEP
- Status last verified
- Jan 2026
- First submitted
- 6 Feb 2025
- Last updated
- 23 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP
- ClinicalTrials.gov ID
- NCT06820983
- Acronym / sponsor ID
- EQOPEP / PI2024_843_0118
- Conditions
- Bronchiectasis, Quality of Life, Physiotherapy
- Keywords
- quality of life, Bronchiectasis, oscillating PEP devices, physiotherapy
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire, AmiensUniversity, hospital or other
- Collaborators
- Hôpital Armand Trousseau
- Study start
- 17 Oct 2024 (actual)
- Primary completion
- Apr 2026 (estimated)
- Study completion
- Apr 2026 (estimated)
- First posted
- 11 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Parallel groups
- Masking
- None (open label)
Who may qualify
- Ages
- 8 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP.
- The study population will be clinically stable and will be seen in follow-up consultations.
Key exclusion criteria (7 listed)
- Children under 8 years of age.
- Patients who use an OPEP
- Patients in the acute exacerbation phase of their DDB
- Patients who are not under regular consultation
- Patients with severe, uncontrolled co-morbidities
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| adult questionnary for parents of children aged 8 to 13Quality of life questionnaire for parents of children aged 8 to 13 | Other | – |
| Quality of life questionnaire for children aged 8 to 13Quality of life questionnaire for children aged 8 to 13 | Other | – |
| Quality of life questionnaire for adolescents aged 14 to 17Quality of life questionnaire for adolescents aged 14 to 17 | Other | – |
| Quality of life questionnaire for adultsQuality of life questionnaire for adults | Other | – |
| A satisfaction adherence questionnaireA satisfaction adherence questionnaire will also be distributed to patients after several months' use of oscillating PEP | Other | – |
Primary outcome
Variation of patient quality of life before and after OPEP installation
Time frame: 18 months
quality of life is determined by qustionnaire
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Bronchiectasis
RecruitingPhase 2
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Recruiting
THERMotherapy Against Persistent Bacterial LUNG Infections
Lung Diseases, Obstructive, Bronchiectasis
RecruitingObservational study
Natural History of Bronchiectasis
Bronchiectasis, Cystic Fibrosis
RecruitingPhase 1
Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal Impairment
Non-cystic Fibrosis Bronchiectasis (NCFBE)
Not yet recruitingPhase 3
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
Bronchiectasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing adult questionnary for parents of children aged 8 to 13, Quality of life questionnaire for children aged 8 to 13 and Quality of life questionnaire for adolescents aged 14 to 17 in people with Bronchiectasis and Quality of Life, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 23 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Thomas PINTO, MD (33+3 22 08 80 00, pinto.thomas@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Variation of patient quality of life before and after OPEP installation (time frame: 18 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2026.